Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$26M Sell
817,311
-40,615
-5% -$1.28M 0.73% 32
2017
Q1
$27.8M Sell
857,926
-24,943
-3% -$786K 0.84% 25
2016
Q4
$27.2M Sell
882,869
-495,938
-36% -$15.1M 0.85% 25
2016
Q3
$44.3M Buy
1,378,807
+51,438
+4% +$1.72M 1.38% 11
2016
Q2
$44.3M Sell
1,327,369
-29,760
-2% -$950K 1.49% 10
2016
Q1
$38.2M Sell
1,357,129
-141,238
-9% -$4.03M 1.26% 12
2015
Q4
$45.9M Sell
1,498,367
-24,337
-2% -$766K 1.58% 8
2015
Q3
$45.4M Buy
1,522,704
+32,326
+2% +$1.04M 1.45% 9
2015
Q2
$47.4M Sell
1,490,378
-751,463
-34% -$24.5M 1.48% 11
2015
Q1
$74M Sell
2,241,841
-758,746
-25% -$24.1M 2.3% 7
2014
Q4
$88.7M Buy
3,000,587
+197,700
+7% +$5.67M 2.63% 4
2014
Q3
$315M Sell
2,802,887
-185,129
-6% -$5.2M 2.85% 6
2014
Q2
$84.1M Buy
2,988,016
+615,471
+26% +$17.5M 2.64% 6
2014
Q1
$72.3M Buy
2,372,545
+1,714,171
+260% +$51.1M 2.46% 9
2013
Q4
$19.1M Buy
658,374
+435,366
+195% +$12.7M 0.67% 38
2013
Q3
$6.08M Buy
223,008
+30,329
+16% +$825K 0.23% 96
2013
Q2
$5.12M Buy
+192,679
New +$5.32M 0.2% 105

Other funds holding PFE

Delta Lloyd's PFE Position: Q2 2017 in Review

Delta Lloyd reduced its Pfizer (PFE) stake by 4.7% in Q2 2017, selling an estimated $1.28M and leaving 817,311 shares worth $26M. The position accounts for 0.73% of the portfolio, ranked #32.

Delta Lloyd first reported a position in PFE in Q2 2013 and has held it in 17 quarters since. The position peaked at $315M in Q3 2014. 2,049 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

  • Delta Lloyd held 817,311 shares of Pfizer worth $26M as of Q2 2017.
  • Delta Lloyd sold 40,615 Pfizer shares in Q2 2017, an estimated $1.28M.
  • Pfizer made up 0.73% of Delta Lloyd's portfolio in Q2 2017, its #32 holding.
  • Delta Lloyd first reported a position in Pfizer in Q2 2013 and has held it in 17 quarters since.
  • Delta Lloyd's Pfizer position peaked at $315M in Q3 2014.
  • 2,049 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Delta Lloyd's 13F filing for Q2 2017, filed 9 Aug 2017.